American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.
“The AADA urged the FDA to ban indoor tanning devices because they emit ultraviolet radiation that has been shown to cause skin cancer including melanoma, the deadliest form of skin cancer,” said Dr. James. “Compelling, irrefutable scientific evidence shows that indoor tanning is causing skin cancer in our young people and that is unacceptable,” he said. “At the very least, we encourage the FDA to shift the classification of indoor tanning to one that more closely matches the health risks of these devices and place additional regulations on these harmful devices,” he said.
The AADA supports a ban on the production and sale of indoor tanning equipment for non-medical purposes. However, until this action occurs, the AADA supports shifting the classification of indoor tanning devices to the strongest possible category and placing additional restrictions on indoor tanning to protect the health and safety of Americans. These restrictions include:
- Prohibiting access to indoor tanning for minors (under 18 years old)
- Educating all indoor tanning customers about the skin cancer risks and requiring their informed consent
- Implementing and enforcing labeling recommendations outlined in the Tanning Accountability and Notification (TAN) Act
- Encouraging enforcement of state regulations